Now Available: Final Rule for FDAAA 801 and NIH Policy on Clinical Trial Reporting
1 study found for:    NCT01835223
Show Display Options
Rank Status Study
1 Recruiting Tivozanib in Treating Patients With Liver Cancer That Is Metastatic or Cannot Be Removed by Surgery
Conditions: Advanced Adult Hepatocellular Carcinoma;   Non-Resectable Hepatocellular Carcinoma
Interventions: Other: Laboratory Biomarker Analysis;   Other: Pharmacological Study;   Drug: Tivozanib

Indicates status has not been verified in more than two years